EUVIMED · CrossrefZeitschrift
Expert Opinion on Therapeutic Targets
ISSN 1472-8222 · Informa UK Limited
Neueste Artikel
Targeting disease pathways in Alzheimer’s utilizing lithium compounds
Molecular targets for the treatment of sarcopenia: a geroscience approach
Prospective molecular targets for the future of thyroid eye disease treatment
Prospects of targeting GPR37 for neurotherapeutics
SFRP1 as a therapeutic target in Alzheimer’s disease: a druggable molecule involved in amyloid, synaptic, and inflammatory pathology
Structural and mechanistic insights for calpain drug development
Potential for targeting peroxisome proliferator-activated receptor gamma in type 2 diabetes
Therapeutic targeting of colony stimulating factor 1 receptor
Melatonin ameliorates renal fibrosis by disrupting the DANCR/QK-mediated stabilization of MALAT1 and inhibiting Galectin-3-dependent macrophage polarization
Understanding the roles of interleukin-33: is there promise for therapeutic targeting?
What are the potentials of the different sirtuin proteins as therapeutic targets?
Molecular advancements in targeting fibroblast activation protein (FAP) in cancer therapies
CCL11 as a cancer target: molecular role and the mechanisms for potential therapeutic intervention
In the wisdom of Odin: modular architecture, receptor trafficking and therapeutic implications
Molecular insights into GLP-1 receptor agonists and emerging metabolic-inflammatory targets in hidradenitis suppurativa
Extracellular vesicles redefine immune modulation through Toll-like receptor networks
Targeting the LOX-1 scavenger receptor for therapeutics and diagnostics
Structure-guided targeting of Plasmodium falciparum aminopeptidase P: exploiting S4’ dimer-interface interactions for selective antimalarial drug design
Senolytics for cancer treatment: complexities and opportunities
Targeting protein misfolding and aggregation in neurodegenerative diseases: challenges for the identification and validation of targets for small molecules
Overcoming adaptive resistance to cancer immunotherapy: molecular targeting strategies for the tumor microenvironment
Vav1 targeting for cancer therapeutics: mechanistic understanding and preclinical promise
New and emerging therapeutics and molecular targets for attention-deficit hyperactivity disorder
Targeting the NLRP3 inflammasome pathway associated with neuroinflammation mediated Alzheimer’s disease: pre-clinical and clinical status of emerging therapeutics
Advances in CGRP therapeutic targets for migraine: where do we stand 5 years later?
Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver disease
Identifying targets at the blood-brain barrier for treating vascular cognitive impairment and dementia
Targeting the NLRP3 inflammasome with antibody-based therapeutics for chronic neurodegenerative diseases
Uncovering targets and molecular pathways for personalizing treatment in epilepsy
Feasibility of remnant cholesterol as a therapeutic target for atherosclerotic cardio-vascular disease
EUVIMED